These results suggest that utilizing deregulated E2F activity, unique to cancer cells, to activate an ARF promoter-driven TK construct, will enable cancer-cell specific ganciclovir-mediated cell death, while preserving normal growing cells. The gene discussed is CDKN2A; the disease is cancer.